A cardiologist by training, Nathan has been with Frazier Healthcare Partners since 1999. He has led exited investments, including BARRX, Zeltiq, Glaukos, PCI, Abode Healthcare, Silvergate Pharma, Powervision, and HOPCo. He currently serves on the Boards of Adare Pharma Services, Apollo Intelligence, CPS Solutions, Caravel Autism Health, EPTAM Precision, and HOPCo/CORE Orthopedics. He previously served on the PRI Investment Committee of the Bill and Melinda Gates Foundation.
Prior to joining Frazier, Nathan was an Associate Professor of Medicine and the Director of the Cardiovascular Outcomes Research Center (CORC) at the University of Washington.
Nathan earned an MD from Emory University School of Medicine and a Masters of Public Health (MPH) from the University of Washington.
Emory University School of Medicine (MD)
University of Washington School of Public Health (MPH)
University of Pennsylvania (BA)